Lafen: Medgend

Lafen FDA Approved Drugs

DESCOVY [Emtricitabine^{C₈H₁₀FN₃O₃S} : Tenofovir Alafenamide Fumarate^{2C₂₁H₂₉N₆O₅PC₄H₄O₄}]

200mg : eq 25mg base (oral tablet)

Gilead Sciences Inc^{Apr 4, 2016}

Treatment of hiv infection.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

GENVOYA [Cobicistat^{C₄₀H₅₃N₇O₅S₂} : Elvitegravir^{C₂₃H₂₃ClFNO₅} : Emtricitabine^{C₈H₁₀FN₃O₃S} : Tenofovir Alafenamide Fumarate^{2C₂₁H₂₉N₆O₅PC₄H₄O₄}]

150mg : 150mg : 200mg : eq 10mg base (oral tablet)

Gilead Sciences Inc^{Nov 5, 2015}

Treatment of hiv infection using a composition containing a pharmacokinetic enhancer that inhibits cytochrome p450 monooxygenase.
Treatment of hiv infection.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

NABUMETONE [Nabumetone^{C₁₅H₁₆O₂}]

500mg (oral tablet)

750mg (oral tablet)

Apotex Inc^{Dec 30, 2011}
Chartwell Molecules^{Jan 24, 2003}
Impax Labs Inc^{May 26, 2000}
Invagen Pharms^{Mar 7, 2008}
Lupin Ltd^{Jan 12, 2011}
Mylan Pharms Inc^{Jul 12, 2010}
Sandoz^{Feb 25, 2002}
Watson Labs^{Jun 13, 2011}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ODEFSEY [Emtricitabine^{C₈H₁₀FN₃O₃S} : Rilpivirine Hydrochloride^{C₂₂H₁₈N₆ClH} : Tenofovir Alafenamide Fumarate^{2C₂₁H₂₉N₆O₅PC₄H₄O₄}]

200mg : eq 25mg base : eq 25mg base (oral tablet)

Gilead Sciences Inc^{Mar 1, 2016}

Treatment of hiv infection.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

VEMLIDY [Tenofovir Alafenamide Fumarate^{2C₂₁H₂₉N₆O₅PC₄H₄O₄}]

eq 25mg base (oral tablet)

Gilead Sciences Inc^{Nov 10, 2016}

Treatment of chronic hepatitis b in adult patients.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Lafen FDA Approved Drugs